Arcosa (ACA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
31 Mar, 2026Executive summary
Achieved record financial results in 2025, with $2.88B in revenue and $583.3M in adjusted EBITDA, reflecting a 30% increase over 2024 and a 20.2% adjusted EBITDA margin.
Advanced portfolio transformation through strategic acquisitions and divestitures, notably the Stavola acquisition and Steel Components divestiture.
Deleveraged balance sheet, reaching a net debt to adjusted EBITDA ratio of 2.27, two quarters ahead of target.
Integrated sustainability into strategy, achieving milestones such as a 10% reduction goal in GHG emissions intensity by end of 2026 and multiple third-party certifications.
Enhanced safety culture, with a 10% decline in TRIR and 35% decline in DART year-over-year.
Voting matters and shareholder proposals
Election of nine incumbent directors for one-year terms expiring at the 2027 annual meeting.
Advisory vote on named executive officer compensation (Say-on-Pay).
Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026.
Shareholder proposals for the 2027 proxy statement must be received by December 1, 2026.
Board of directors and corporate governance
Board consists of nine members, eight of whom are independent; all committees are 100% independent.
Board leadership is separated, with an independent non-executive chairman.
Annual board and committee self-evaluations, majority voting policy, and proxy access for director nominations.
Robust director and officer stock ownership requirements and policies prohibiting hedging, pledging, and short sales.
Board succession planning and diversity of skills and experience are emphasized.
Latest events from Arcosa
- Vote on nine directors, executive pay, and auditor ratification at the May 2026 meeting.ACA
Proxy filing31 Mar 2026 - Record 2025 growth, barge divestiture, and strong 2026 EBITDA outlook with margin expansion.ACA
Q4 202527 Feb 2026 - Record Q2 results, $1.2B Stavola deal, and portfolio actions drive growth and margin gains.ACA
Q2 20242 Feb 2026 - Transformational acquisition boosts aggregates to 65% of EBITDA, fueling growth and margin expansion.ACA
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 2024 Adjusted EBITDA rose 39% with margin gains and raised guidance after major portfolio moves.ACA
Q3 202417 Jan 2026 - Double-digit growth, margin expansion, and strong cash flow set up 30% EBITDA growth for 2025.ACA
Q4 202421 Dec 2025 - Strong financials, board independence, and sustainability drive 2025 proxy proposals.ACA
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, approve executive pay, and ratify auditor, all board-backed.ACA
Proxy Filing1 Dec 2025 - Record Q2 2025 revenue and margin growth, with robust outlook and strong segment performance.ACA
Q2 202523 Nov 2025